177 filings
Page 6 of 9
6-K
MDNAF
Medicenna Therapeutics Corp.
27 Apr 22
Medicenna Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference
7:15am
6-K
MDNAF
Medicenna Therapeutics Corp.
8 Apr 22
Medicenna Presents Preclinical Data Demonstrating Anti-Cancer Activity of a Long-Acting IL-13 Super-Antagonist at the AACR Annual Meeting
9:22am
6-K
MDNAF
Medicenna Therapeutics Corp.
8 Apr 22
Medicenna Announces Preclinical Data Highlighting the Potent Anti-Tumor Efficacy of Anti-PD1-IL-2 BiSKIT at the AACR Annual Meeting
9:21am
6-K
MDNAF
Medicenna Therapeutics Corp.
10 Mar 22
Medicenna Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference
7:15am
6-K
MDNAF
Medicenna Therapeutics Corp.
9 Mar 22
Medicenna Announces Upcoming Poster Presentations at the AACR Annual Meeting
7:15am
6-K
MDNAF
Medicenna Therapeutics Corp.
3 Mar 22
Medicenna Announces Appointment of Clinical Advisory Board and Dr. Kapil Dhingra as Strategic Advisor
7:10am
SC 13G/A
MDNAF
Medicenna Therapeutics Corp.
10 Feb 22
Medicenna Therapeutics / Merchant Fahar ownership change
2:48pm
6-K
MDNAF
Medicenna Therapeutics Corp.
10 Feb 22
Medicenna to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
7:05am
6-K
MDNAF
Medicenna Therapeutics Corp.
9 Feb 22
Interim condensed consolidated financial statements of
7:18am
6-K
MDNAF
Medicenna Therapeutics Corp.
2 Feb 22
Current report (foreign)
7:32am
6-K
MDNAF
Medicenna Therapeutics Corp.
31 Jan 22
Medicenna Announces Formation of its Scientific Advisory Board
7:15am
6-K
MDNAF
Medicenna Therapeutics Corp.
26 Jan 22
Medicenna Announces Peer-Reviewed Publication of Preclinical Data on MDNA11 in the Journal for ImmunoTherapy of Cancer
8:08am
6-K
MDNAF
Medicenna Therapeutics Corp.
18 Jan 22
Medicenna Announces Management Change and Appoints Experienced Development Advisory Committee
7:15am
6-K
MDNAF
Medicenna Therapeutics Corp.
5 Jan 22
Medicenna to Participate in Upcoming January Investor Conferences
9:07am
6-K
MDNAF
Medicenna Therapeutics Corp.
22 Dec 21
Current report (foreign)
7:33am
6-K
MDNAF
Medicenna Therapeutics Corp.
17 Dec 21
Medicenna Receives Regulatory Clearance to Expand the Phase 1/2 ABILITY Study of MDNA11 to Canada
8:00am
6-K
MDNAF
Medicenna Therapeutics Corp.
18 Nov 21
Current report (foreign)
7:15am
6-K
MDNAF
Medicenna Therapeutics Corp.
12 Nov 21
Interim condensed consolidated financial statements of
7:15am
6-K
MDNAF
Medicenna Therapeutics Corp.
9 Nov 21
Medicenna Therapeutics to Present at Stifel’s Virtual Healthcare Conference
8:23am
6-K
MDNAF
Medicenna Therapeutics Corp.
4 Nov 21
Current report (foreign)
9:00am